Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Acute Pancreatitis
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium longum

Bifidobacterium longum

DIETARY_SUPPLEMENT

Placebo

Placebo

COMBINATION_PRODUCT

Standard clinical treatment

Fasting, gastrointestinal decompression, rehydration, inhibition of pancreatic fluid and pancreatic enzyme secretion, improvement of microcirculation, and support of organ function if organ dysfunction occurs at a later stage (mechanical ventilation, continuous renal replacement therapy, and the use of vasoactive drugs).

Trial Locations (1)

330006

The First Affiliated Hospital of Nanchang University, Nanchang

All Listed Sponsors
lead

The First Affiliated Hospital of Nanchang University

OTHER

NCT06639516 - Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial | Biotech Hunter | Biotech Hunter